Ftse Mib
33.968,78
1,01%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.506,18
-0,76%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Harvard Bioscience Inc (HBIO) Harvard Bioscience Inc (HBIO) Notizie

Harvard Bioscience Inc

HBIO
3,92
0,07 (1,82%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:16:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202414:45GLOBEHarvard Bioscience Schedules First Quarter 2024 Earnings..
09/4/202415:00GLOBEHarvard Bioscience Announces Action to Improve Operational..
11/3/202413:00GLOBEHarvard Bioscience, Inc. to Participate in March 2024..
07/3/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:00EDGAR2Form 8-K - Current report
07/3/202413:00GLOBEHarvard Bioscience Announces Fourth Quarter 2023 Financial..
06/3/202414:30GLOBEHarvard Bioscience to Showcase Latest Solutions for..
27/2/202423:10GLOBEHarvard Bioscience Schedules Fourth Quarter 2023 Earnings..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202423:01EDGAR2Form 8-K - Current report
03/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:40GLOBEHarvard Bioscience to Present at Benchmark Company’s..
09/11/202322:30GLOBEHarvard Bioscience to Present at Southwest IDEAS Investor..
07/11/202322:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEHarvard Bioscience Announces Third Quarter 2023 Financial..
06/11/202322:30GLOBEHarvard Bioscience to Showcase Latest Innovations in..
30/10/202314:00GLOBEHarvard Bioscience Schedules Third Quarter 2023 Earnings..
18/9/202314:57GLOBEHarvard Bioscience and Etisense Announce Agreement for..
21/8/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202323:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:05EDGAR2Form 8-K - Current report
08/8/202313:18GLOBEHarvard Bioscience Announces Second Quarter 2023 Financial..
04/8/202300:30GLOBEHarvard Bioscience to Present at Sidoti Virtual Investor..
28/7/202300:36GLOBEHarvard Bioscience Schedules Second Quarter 2023 Earnings..
22/6/202313:55GLOBEHarvard Bioscience Set to Join Russell 2000® and 3000®..
20/6/202314:01GLOBEHarvard Bioscience Appoints Jennifer Cote as Chief Financial..
Apertura: 3,91 Min: 3,90 Max: 4,08
Chiusura: 3,85

La tua Cronologia

NASDAQ
HBIO
Harvard Bioscience
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network